Who owns CRVS? 13F holders and whale ownership
CRVS is tracked across public portfolios in Whale Analyzer. This page answers who owns CRVS, which top funds are buying CRVS, aggregate disclosed value, and recent position changes based on public data.
Open interactive stock dashboardTop holders
| Investor | Reported value | Shares | Change |
|---|---|---|---|
| Samuel Isaly 13F portfolio OrbiMed Advisors holdings | $104.8M | 7.2M | Held |
| Joseph Edelman 13F portfolio Perceptive Advisors holdings | $33.5M | 2.3M | Increased |
| Peter Kolchinsky 13F portfolio RA Capital Management holdings | $6.6M | 450.0K | New |
How to read this page
Values are reported public positions from tracked investors and institutions. They are not real-time ownership totals for the company.
Related stock holder pages
- EWTX whale holders — EDGEWISE THERAPEUTICS INC
- ELVN whale holders — ENLIVEN THERAPEUTICS INC
- LLY whale holders — ELI LILLY & CO
- SVA whale holders — SINOVAC BIOTECH LTD
- BSX whale holders — BOSTON SCIENTIFIC CORP
- SION whale holders — SIONNA THERAPEUTICS INC
- AZN whale holders — ASTRAZENECA PLC
- MYGN whale holders — MYRIAD GENETICS INC
Learn more in Whale Analyzer Academy
Frequently asked questions
Who owns CRVS stock?
Whale Analyzer tracks 3 public institutional holders of CRVS with a combined reported value of $144.9M. See the holder table above for the largest tracked positions.
Which top funds are buying CRVS?
Check the "Change" column in the holders table above. "New" means a fresh position was initiated, "Added" means an existing position was increased, and "Reduced" or "Sold" indicates trimming.
What does 13F ownership mean for CRVS?
Use the interactive CRVS dashboard on Whale Analyzer for real-time holder analysis, or read our 13F Alpha Signals Guide.